Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
Abstract Comprehensive analysis of clinical samples has recently identified molecular and immunological classification of hepatocellular carcinoma (HCC), and the CTNNB1 (β-catenin)-mutated subtype exhibits distinctive characteristics of immunosuppressive tumor microenvironment. For clarifying the mo...
Enregistré dans:
Auteurs principaux: | Masafumi Akasu, Shu Shimada, Ayano Kabashima, Yoshimitsu Akiyama, Masahiro Shimokawa, Keiichi Akahoshi, Atsushi Kudo, Shoji Yamaoka, Minoru Tanabe, Shinji Tanaka |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/63c7a6b15ee74a9d819e44b8f20fa851 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
par: Franciscus C. Vermeer, et autres
Publié: (2021) -
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
par: Tomohiko Yamamura, et autres
Publié: (2020) -
Machine learning based CRISPR gRNA design for therapeutic exon skipping.
par: Wilson Louie, et autres
Publié: (2021) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
par: Gang Han, et autres
Publié: (2016) -
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy
par: Pablo Beckers, et autres
Publié: (2021)